Strona główna
  • Zamawiaj do paczkomatu
  • Płać wygodnie
  • Zastrzyk życia
  • Obniżka
Renal Cell Cancer, An Issue of Hematology/Oncology Clinics of North America

Renal Cell Cancer, An Issue of Hematology/Oncology Clinics of North America

9780323938990
PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 14 DAYS
483,79 zł
411,22 zł Zniżka 72,57 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 411,22 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DHL, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
In this issue of Hematology/Oncology Clinics, guest editors Drs. Bradley A. McGregor and Toni K. Choueiri bring their considerable expertise to the topic of Renal Cell Cancer. Top experts in the field cover key topics such as VHL and HIF at the center of renal cell cancer biology; immunobiology and metabolic pathways of renal cell cancer; hereditary renal cell cancer syndromes; the role of the pathologist in renal cell cancer; novel imaging in renal cell cancer; and more.
Szczegóły produktu
Elsevier
98512
9780323938990
9780323938990

Opis

Rok wydania
2023
Numer wydania
1
Oprawa
twarda
Liczba stron
240
Wymiary (mm)
152 x 229
Waga (g)
540
  • von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology
    Immunobiology and Metabolic Pathways of Renal Cell Carcinoma
    Hereditary Renal Cell Carcinoma Syndromes
    The Role of the Pathologist in Renal Cell Carcinoma Management
    Insights into Renal Cell Carcinoma with Novel Imaging Approaches
    Surgical Management of Localized Disease and Small Renal Masses
    Role of Surgery in Metastatic Renal Cell Carcinoma
    Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma
    Role of Radiation in Treatment of Renal Cell Carcinoma
    Prognostic Models in Metastatic Renal Cell Carcinoma
    Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma
    Managing First-Line Metastatic Renal Cell Carcinoma: Favorable-Risk Disease
    First-Line Treatment for Intermediate and Poor Risk Advanced or Metastatic Clear Cell Renal Cell Carcinoma
    Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy
    Renal Cell Carcinoma of Variant Histology: Biology and Therapies
    Toxicity Management of Systemic Kidney Cancer Therapies
    Management of Brain Metastases in Metastatic Renal Cell Carcinoma
    Novel Targeted Therapies for Renal Cell Carcinoma: Building on the Successes of Vascular Endothelial Growth Factor and mTOR Inhibition
    Novel Immune Therapies for Renal Cell Carcinoma: Looking Beyond the Programmed Cell Death Protein 1 and Cytotoxic T-Lymphocyte-Associated Protein 4 Axes
Komentarze (0)
Ostatnio przeglądane